These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 34001809)

  • 1. Evaluating different low-density lipoprotein cholesterol thresholds to initiate statin for prevention of cardiovascular diseases in patients with type 2 diabetes mellitus: A target trial emulation study.
    Wan EYF; Xu W; Mok AHY; Chin WY; Yu EYT; Chui CSL; Chan EWY; Wong ICK; Lam CLK; Danaei G
    Diabetes Obes Metab; 2024 May; 26(5):1877-1887. PubMed ID: 38379445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visit-to-visit variability of blood pressure and risk of macrovascular and microvascular complications in patients with type 2 diabetes: A Chinese primary-care cohort study.
    Deng Y; Liu Y; Zhang S; Yu H; Zeng X; An R; Chen Z; Sun N; Yin X; Dong Y
    J Diabetes; 2022 Nov; 14(11):767-779. PubMed ID: 36443961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Systolic and Diastolic Blood Pressure Variability Is Correlated with the Occurrence of Peripheral Arterial Disease in the First Decade following a Diagnosis of Type 2 Diabetes Mellitus: A New Biomarker from Old Measurement.
    Yeh CH; Yu HC; Huang TY; Huang PF; Wang YC; Chen TP; Yin SY
    Biomed Res Int; 2016; 2016():9872945. PubMed ID: 27830155
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of change in systolic blood pressure between clinic visits on estimated 10-year cardiovascular disease risk.
    Ye S; Wang YC; Shimbo D; Newman JD; Levitan EB; Muntner P
    J Am Soc Hypertens; 2014 Mar; 8(3):159-65. PubMed ID: 24462238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of BMI and LDL-cholesterol change pattern on cardiovascular disease in normal adults and diabetics.
    Youk TM; Kang MJ; Song SO; Park EC
    BMJ Open Diabetes Res Care; 2020 Dec; 8(2):. PubMed ID: 33355207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Treating Hyperphosphatemia With Lanthanum Carbonate vs Calcium Carbonate on Cardiovascular Events in Patients With Chronic Kidney Disease Undergoing Hemodialysis: The LANDMARK Randomized Clinical Trial.
    Ogata H; Fukagawa M; Hirakata H; Kagimura T; Fukushima M; Akizawa T;
    JAMA; 2021 May; 325(19):1946-1954. PubMed ID: 34003226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of visit-to-visit glycemic variability with risk of cardiovascular diseases in high-risk Japanese patients with type 2 diabetes: A subanalysis of the EMPATHY trial.
    Sato M; Inaishi J; Saisho Y; Sato Y; Komuro I; Itoh H
    J Diabetes Investig; 2021 Dec; 12(12):2190-2196. PubMed ID: 34013644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between testosterone and lipid profiles under statin therapy and its clinical impact on the cardiovascular event risk.
    Nakayama A; Morita H; Kawahara T; Itoh H; Komuro I
    Heart Vessels; 2021 Dec; 36(12):1794-1803. PubMed ID: 34036416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient perceptions and use of non-statin lipid lowering therapy among patients with or at risk for atherosclerotic cardiovascular disease: Insights from the PALM registry.
    Lowenstern A; Li S; Navar AM; Virani SS; Roger VL; Robinson JG; Goldberg AC; Kampman W; Peterson ED; Wang TY
    Clin Cardiol; 2021 Jun; 44(6):863-870. PubMed ID: 34008247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Blood Pressure Classification Using the 2017 ACC/AHA Blood Pressure Guideline and Retinal Atherosclerosis.
    Matsuoka S; Kaneko H; Yano Y; Itoh H; Fukui A; Morita K; Kiriyama H; Kamon T; Fujiu K; Seki H; Michihata N; Jo T; Takeda N; Morita H; Nakamura S; Yokoo T; Nishiyama A; Node K; Yasunaga H; Komuro I
    Am J Hypertens; 2021 Oct; 34(10):1049-1056. PubMed ID: 34008020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bempedoic Acid for Heterozygous Familial Hypercholesterolemia: From Bench to Bedside.
    Agarwala A; Quispe R; Goldberg AC; Michos ED
    Drug Des Devel Ther; 2021; 15():1955-1963. PubMed ID: 34007155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Achieving LDL cholesterol target levels <1.81 mmol/L may provide extra cardiovascular protection in patients at high risk: Exploratory analysis of the Standard Versus Intensive Statin Therapy for Patients with Hypercholesterolaemia and Diabetic Retinopathy study.
    Itoh H; Komuro I; Takeuchi M; Akasaka T; Daida H; Egashira Y; Fujita H; Higaki J; Hirata KI; Ishibashi S; Isshiki T; Ito S; Kashiwagi A; Kato S; Kitagawa K; Kitakaze M; Kitazono T; Kurabayashi M; Miyauchi K; Murakami T; Murohara T; Node K; Ogawa S; Saito Y; Seino Y; Shigeeda T; Shindo S; Sugawara M; Sugiyama S; Terauchi Y; Tsutsui H; Ueshima K; Utsunomiya K; Yamagishi M; Yamazaki T; Yo S; Yokote K; Yoshida K; Yoshimura M; Yoshimura N; Nakao K; Nagai R;
    Diabetes Obes Metab; 2019 Apr; 21(4):791-800. PubMed ID: 30393955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.
    Querton L; Buysschaert M; Hermans MP
    J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensive statin therapy for Indians: Part-I. Benefits.
    Enas EA; Pazhoor HC; Kuruvila A; Vijayaraghavan K
    Indian Heart J; 2011; 63(3):211-27. PubMed ID: 22734339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of statin intensive therapy in type 2 diabetes mellitus with high visit-to-visit blood pressure variability.
    Ikeda S; Shinohara K; Enzan N; Matsushima S; Tohyama T; Funakoshi K; Kishimoto J; Itoh H; Komuro I; Tsutsui H
    J Hypertens; 2021 Jul; 39(7):1435-1443. PubMed ID: 34001809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of intensive lipid-lowering therapy with statins stratified by blood pressure levels in patients with type 2 diabetes mellitus and retinopathy: Insight from the EMPATHY study.
    Shinohara K; Ikeda S; Enzan N; Matsushima S; Tohyama T; Funakoshi K; Kishimoto J; Itoh H; Komuro I; Tsutsui H
    Hypertens Res; 2021 Dec; 44(12):1606-1616. PubMed ID: 34526672
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.